Loss of anchorage in checkpoint-deficient cells increases genomic instability and promotes oncogenic transformation

Journal of Cell Science

Volumn 122, Issue 18, 2009, Pages 3272-3281

  Cremona, Catherine A ^a,b,c   Lloyd, Alison C ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Anchorage; Genomic stability; LT; P27

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DNA; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL ANCHORAGE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL PROTECTION; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DNA REPLICATION; GENOMIC INSTABILITY; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT;

ANIMALS; CELL ADHESION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; GENOMIC INSTABILITY; HUMANS; MESENCHYMAL STEM CELLS; MICE; RATS; S PHASE;

MAMMALIA;

EID: 70350365289     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.047126     Document Type: Article

References (43)

1. Assoian, R. K. and Schwartz, M. A. (2001). Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression. Curr. Opin. Genet. Dev. 11, 48-53.
2. Assoian, R. K. and Klein, E. A. (2008). Growth control by intracellular tension and extracellular stiffness. Trends Cell Biol. 18, 347-352.
3. Bartkova, J., Horejsi, Z., Koed, K., Kramer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J., Lukas, C. et al. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870.
4. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V., Kolettas, E., Niforou, K., Zoumpourlis, V. et al. (2006). Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633-637.
5. Blow, J. and Gillespie, P. (2008). Replication licensing and cancer, a fatal entanglement? Nat. Rev. Cancer 8, 799-806.
6. Bryant, P., Zheng, Q. and Pumiglia, K. (2006). Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms. Mol. Cell. Biol. 26, 4201-4213.
7. Chu, I., Hengst, L. and Slingerland, J. (2008). The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat. Rev. Cancer 8, 253-267.
8. Classon, M. and Harlow, E. (2002). The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer 2, 910-917.
9. Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre', M., Nuciforo, P., Bensimon, A. et al. (2006). Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638-642.
10. Elenbaas, B. and Weinberg, R. A. (2001). Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264, 169-184.
11. Fang, F., Orend, G., Watanabe, N., Hunter, T. and Ruoslahti, E. (1996). Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271, 499-502.
12. Freedman, V. H. and Shin, S. I. (1974). Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3, 355-359.
13. Frisch, S. and Francis, H. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619-626.
14. Funes, J. M., Quintero, M., Henderson, S., Martinez, D., Qureshi, U., Westwood, C., Clements, M. O., Bourboulia, D., Pedley, R. B., Moncada, S. et al. (2007). Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proc. Natl. Acad. Sci. USA 104, 6223-6228.
15. Gorgoulis, V., Vassiliou, L. V., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., Ditullio, R., Kastrinakis, N., Levy, B. et al. (2005). Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913.
16. Grimmler, M., Wang, Y., Mund, T., Cilensek, Z., Keidel, E. M., Waddell, M. B., Jäkel, H., Kullmann, M., Kriwacki, R. W. and Hengst, L. (2007). Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128, 269-280.
17. Guadagno, T. M., Ohtsubo, M., Roberts, J. M. and Assoian, R. K. (1993). A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 262, 1572-1575.
18. Hahn, W. C. and Weinberg, R. A. (2002). Rules for making human tumor cells. N. Engl. J. Med. 347, 1593-1603.
19. Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W. and Weinberg, R. A. (1999). Creation of human tumour cells with defined genetic elements. Nature 400, 464-468.
20. Halazonetis, T., Gorgoulis, V. and Bartek, J. (2008). An oncogene-induced DNA damage model for cancer development. Science 319, 1352-1355.
21. Hanahan, D. and Weinberg, R. (2000). The hallmarks of cancer. Cell 100, 57-70.
22. Hauser, P., Ma, L., Agrawal, D., Haura, E., Cress, W. D. and Pledger, W. J. (2004). Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1). Mol. Cancer Res. 2, 96-104.
23. Husemann, Y., Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., Forni, G., Eils, R., Fehm, T., Riethmuller, G. et al. (2008). Systemic spread is an early step in breast cancer. Cancer Cell 13, 58-68.
24. Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G., Lukas, J. and Jackson, S. (2005). ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 8, 37-45.
25. Kawada, M., Yamagoe, S., Murakami, Y., Suzuki, K., Mizuno, S. and Uehara, Y. (1997). Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 15, 629-637.
26. Kawada, M., Uehara, Y., Mizuno, S., Yamori, T. and Tsuruo, T. (1998). Up-regulation of p27Kip1 correlates inversely with anchorage-independent growth of human cancer cell lines. Jpn. J. Cancer Res. 89, 110-115.
27. Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A. and Koff, A. (1996). Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85, 721-732.
28. Malumbres, M., Pevarello, P., Barbacid, M. and Bischoff, J. R. (2008). CDK inhibitors in cancer therapy: what is next? Trends Pharmacol. Sci. 29, 16-21.
29. Mann, D. J. and Jones, N. C. (1996). E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest. Curr. Biol. 6, 474-483.
30. Markey, M. P., Bergseid, J., Bosco, E. E., Stengel, K., Xu, H., Mayhew, C. N., Schwemberger, S. J., Braden, W. A., Jiang, Y., Babcock, G. F. et al. (2007). Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function. Oncogene 26, 6307-6318.
31. Mathon, N. F., Malcolm, D. S., Harrisingh, M. C., Cheng, L. and Lloyd, A. C. (2001). Lack of replicative senescence in normal rodent glia. Science 291, 872-875.
32. Mitchell, P. J., Perez-Nadales, E., Malcolm, D. S. and Lloyd, A. C. (2003). Dissecting the contribution of p16(INK4A) and the Rb family to the Ras transformed phenotype. Mol. Cell. Biol. 23, 2530-2542.
33. Porter, A. (2008). Preventing DNA over-replication: a Cdk perspective. Cell Div. 3, 3.
34. Rajagopalan, H. and Lengauer, C. (2004). Aneuploidy and cancer. Nature 432, 338-341.
35. Ramirez, R. D., Morales, C. P., Herbert, B. S., Rohde, J. M., Passons, C., Shay, J. W. and Wright, W. E. (2001). Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15, 398-403.
36. Roovers, K., Davey, G., Zhu, X., Bottazzi, M. E. and Assoian, R. K. (1999). Alpha5beta1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. Mol. Biol. Cell 10, 3197-3204.
37. Schwartz, M. A. and Assoian, R. K. (2001). Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J. Cell Sci. 114, 2553-2560.
38. Sherr, C. and McCormick, F. (2002). The RB and p53 pathways in cancer. Cancer Cell 2, 103-112.
39. Srinivasan, S. V., Mayhew, C. N., Schwemberger, S., Zagorski, W. and Knudsen, E. S. (2007). RB loss promotes aberrant ploidy by deregulating levels and activity of DNA replication factors. J. Biol. Chem. 282, 23867-23877.
40. Tlsty, T. D. and Coussens, L. M. (2006). Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 1, 119-150.
41. Tort, F., Bartkova, J., Sehested, M., Orntoft, T., Lukas, J. and Bartek, J. (2006). Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis. Cancer Res. 66, 10258-10263.
42. Vaziri, C., Saxena, S., Jeon, Y., Lee, C., Murata, K., Machida, Y., Wagle, N., Hwang, D. S. and Dutta, A. (2003). A p53-dependent checkpoint pathway prevents rereplication. Mol. Cell 11, 997-1008.
43. Zhu, X., Ohtsubo, M., Böhmer, R. M., Roberts, J. M. and Assoian, R. K. (1996). Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133, 391-403.